Literature DB >> 18432524

Hydroxycarbamide associated platelet count oscillations in a patient with polycythaemia vera. A case report and review of the literature.

John Burthem1, Mohammed Suhail Chaudhry.   

Abstract

We describe an unusual case of oscillating platelet counts in a patient with polycythaemia vera. Following commencement of cytoreductive hydroxycarbamide therapy, episodes of thrombocytopenia were followed regularly by thrombocytosis. Platelet counts fluctuated periodically between approximately 200 and 800 x 109/l, with a 28 day cycle duration. Frequent adjustment of the hydroxycarbamide dose was not successful in preventing the oscillations in platelet count. In contrast, maintenance of a constant dose led to a gradual damping of the cycles and thus termination of the large oscillations. The case further implicates hydroxycarbamide as a potential cause of cyclic variations in platelet counts, and demonstrates that cessation of this drug is not always necessary in order to treat this phenomenon.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18432524     DOI: 10.1080/09537100701882053

Source DB:  PubMed          Journal:  Platelets        ISSN: 0953-7104            Impact factor:   3.862


  3 in total

1.  Hydroxyurea induced oscillations in twelve patients with polycythemia vera.

Authors:  Jan Tauscher; Fabian Siegel; Petro E Petrides
Journal:  Haematologica       Date:  2010-03-10       Impact factor: 9.941

2.  Oscillatory haematopoiesis in adults with sickle cell disease treated with hydroxycarbamide.

Authors:  John H Baird; Caterina P Minniti; Jung-Min Lee; Xin Tian; Colin Wu; Mary Jackson; Shoaib Alam; James G Taylor; Gregory J Kato
Journal:  Br J Haematol       Date:  2014-11-06       Impact factor: 6.998

Review 3.  Primary Immune Thrombocytopenia and Essential Thrombocythemia: So Different and yet Somehow Similar-Cases Series and a Review of the Literature.

Authors:  Marta Sobas; Maria Podolak-Dawidziak; Krzysztof Lewandowski; Michał Bator; Tomasz Wróbel
Journal:  Int J Mol Sci       Date:  2021-10-09       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.